Published in Kidney Int Suppl on April 01, 2008
Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients. Clin J Am Soc Nephrol (2011) 1.36
Characterization of the BRAZPD II cohort and description of trends in peritoneal dialysis outcome across time periods. Perit Dial Int (2014) 0.95
A Brazilian experience in assisted automated peritoneal dialysis: a reliable and effective home care approach. Perit Dial Int (2013) 0.91
Body size and longitudinal body weight changes do not increase mortality in incident peritoneal dialysis patients of the Brazilian peritoneal dialysis multicenter study. Clinics (Sao Paulo) (2013) 0.82
Longitudinal changes in health-related quality of life scores in Brazilian incident peritoneal dialysis patients (BRAZPD): socio-economic status not a barrier. Perit Dial Int (2013) 0.78
Novel predictors of peritonitis-related outcomes in the BRAZPD cohort. Perit Dial Int (2014) 0.77
Back to basics: pitting edema and the optimization of hypertension treatment in incident peritoneal dialysis patients (BRAZPD). PLoS One (2012) 0.76
Comparing the Effect of Dressing Versus No-dressing on Exit Site Infection and Peritonitis in Chronic Ambulatory Peritoneal Dialysis Patients. Adv Biomed Res (2017) 0.75
Hand hygiene in peritoneal dialysis patients: a comparison of two techniques. Perit Dial Int (2013) 0.75
Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int (2006) 2.82
Adenosine receptors and calcium: basis for proposing a third (A3) adenosine receptor. Prog Neurobiol (1986) 2.26
Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease? J Intern Med (2007) 1.97
The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions. Br J Pharmacol (1975) 1.71
Inhibition by ATP of hippocampal synaptic transmission requires localized extracellular catabolism by ecto-nucleotidases into adenosine and channeling to adenosine A1 receptors. J Neurosci (1998) 1.65
Effect of adenosine on carotid chemoreceptor activity in the cat. Br J Pharmacol (1981) 1.45
Clinical determinants and mortality predictability of stearoyl-CoA desaturase-1 activity indices in dialysis patients. J Intern Med (2012) 1.40
[Efficiency of D-xilose and triglycerides absorption tests in the investigation of chronic diarrhea]. Arq Gastroenterol (1992) 1.39
Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. Am J Kidney Dis (2000) 1.39
Asymptomatic giardiasis does not affect iron absorption in children with iron deficiency anemia. J Am Coll Nutr (1996) 1.38
Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. J Intern Med (2007) 1.36
Five years' experience with a right atrial catheter for prolonged parenteral nutrition at home. Surg Gynecol Obstet (1976) 1.34
High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis (1997) 1.27
Is follow up of patients after surgery for breast cancer worthwhile? J R Soc Med (1985) 1.27
On the specificity and type of receptor involved in carotid body chemoreceptor activation by adenosine in the cat. Br J Pharmacol (1983) 1.26
Adenosine A2 receptor-mediated excitatory actions on the nervous system. Prog Neurobiol (1996) 1.24
Fine-tuning neuromodulation by adenosine. Trends Pharmacol Sci (2000) 1.22
Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease. J Intern Med (2007) 1.20
Adenosine and adenosine triphosphate decrease 45Ca uptake by synaptosomes stimulated by potassium. Biochem Pharmacol (1979) 1.20
Epidemic nephritis in Nova Serrana, Brazil. Lancet (2000) 1.19
Adenosine: does it have a neuroprotective role after all? Brain Res Brain Res Rev (2000) 1.18
Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J Neurochem (1996) 1.17
Evidence for functionally important adenosine A2a receptors in the rat hippocampus. Brain Res (1994) 1.17
On the type of receptor involved in the inhibitory action of adenosine at the neuromuscular junction. Br J Pharmacol (1985) 1.13
Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats. J Neurophysiol (1999) 1.13
ATP as a presynaptic modulator. Life Sci (2000) 1.12
Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant (1999) 1.09
Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition. Neuroscience (2002) 1.09
Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve ending of the rat. Br J Pharmacol (1991) 1.08
Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis. J Intern Med (2010) 1.08
The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines. Br J Pharmacol (1990) 1.07
Interactions between adenosine and phorbol esters or lithium at the frog neuromuscular junction. Br J Pharmacol (1990) 1.07
Mechanisms of depression of neuromuscular transmission by ATP and adenosine. J Physiol (Paris) (1978) 1.07
Evidence for the presence of excitatory A2 adenosine receptors in the rat hippocampus. Neurosci Lett (1992) 1.07
Non-medical factors that impact on ESRD modality selection. Kidney Int Suppl (1993) 1.06
On the adenosine receptor and adenosine inactivation at the rat diaphragm neuromuscular junction. Br J Pharmacol (1988) 1.05
Ventilatory effects of adenosine mediated by carotid body chemoreceptors in the rat. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.04
Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides. Br J Pharmacol (1996) 1.04
Purinergic modulation of transmitter release. J Theor Biol (1979) 1.01
Human liver sinusoidal endothelial cells induce apoptosis in activated T cells: a role in tolerance induction. Gut (2006) 1.01
Presynaptic A1 inhibitory/A2A facilitatory adenosine receptor activation balance depends on motor nerve stimulation paradigm at the rat hemidiaphragm. J Neurophysiol (1996) 1.01
Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients. Eur J Clin Invest (2008) 1.00
The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality. QJM (2008) 1.00
Enhancement of long-term potentiation by brain-derived neurotrophic factor requires adenosine A2A receptor activation by endogenous adenosine. Neuropharmacology (2008) 0.99
Increased plasma and endothelial cell expression of chemokines and adhesion molecules in chronic kidney disease. Nephron Clin Pract (2009) 0.99
ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus. Br J Pharmacol (1997) 0.97
Tonic adenosine A2A receptor activation modulates nicotinic autoreceptor function at the rat neuromuscular junction. Eur J Pharmacol (1994) 0.97
Excitatory and inhibitory effects of A1 and A2A adenosine receptor activation on the electrically evoked [3H]acetylcholine release from different areas of the rat hippocampus. J Neurochem (1994) 0.97
Inhibitory actions of methionine-enkephalin and morphine on the cat carotid chemoreceptors. Br J Pharmacol (1980) 0.96
Enhancement of transmission at the frog neuromuscular junction by adenosine deaminase: evidence for an inhibitory role of endogenous adenosine on neuromuscular transmission. Neurosci Lett (1985) 0.96
Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees. Cancer Res (1997) 0.96
Purine effects at the neuromuscular junction and their modification by theophylline, imidazole and verapamil. Arch Int Pharmacodyn Ther (1979) 0.96
Solubilized rat brain adenosine receptors have two high-affinity binding sites for 1,3-dipropyl-8-cyclopentylxanthine. J Neurochem (1991) 0.95
Action of adenosine triphosphate on endplate potentials recorded from muscle fibres of the rat-diaphragm and frog sartorius. Br J Pharmacol (1973) 0.95
Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patients. Braz J Med Biol Res (2005) 0.95
Adenosine uptake and deamination regulate tonic A2a receptor facilitation of evoked [3H]acetylcholine release from the rat motor nerve terminals. Neuroscience (1996) 0.94
Inhibition of NMDA receptor-mediated currents in isolated rat hippocampal neurones by adenosine A1 receptor activation. Neuroreport (1995) 0.94
Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. Kidney Int (2000) 0.94
Sevelamer decreases systemic inflammation in parallel to a reduction in endotoxemia. Blood Purif (2010) 0.94
Tropical enteropathy (environmental enteropathy) in early childhood: a syndrome caused by contaminated environment. J Trop Pediatr (1984) 0.94
The fate of circulating lactate dehydrogenase-5 in the rabbit. Clin Sci Mol Med (1976) 0.93
Modification of A1 and A2a adenosine receptor binding in aged striatum, hippocampus and cortex of the rat. Neuroreport (1995) 0.93
Monitoring renal function: measured and estimated glomerular filtration rates - a review. Braz J Med Biol Res (2010) 0.92
Clinical aspects of neurocysticercosis in children. Pediatr Neurol (2000) 0.92
Purinergic modulation of [(3)H]GABA release from rat hippocampal nerve terminals. Neuropharmacology (2000) 0.92
Morphological features of Murray Valley encephalitis virus infection in the central nervous system of Swiss mice. Int J Exp Pathol (2000) 0.92
1,3,8- and 1,3,7-substituted xanthines: relative potency as adenosine receptor antagonists at the frog neuromuscular junction. Br J Pharmacol (1989) 0.91
APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss. Mol Psychiatry (2002) 0.91
Analysis of immunoreactivity to a Streptococcus equi subsp. zooepidemicus M-like protein To confirm an outbreak of poststreptococcal glomerulonephritis, and sequences of M-like proteins from isolates obtained from different host species. J Clin Microbiol (2000) 0.91
Activation of synaptic NMDA receptors by action potential-dependent release of transmitter during hypoxia impairs recovery of synaptic transmission on reoxygenation. J Neurosci (2001) 0.91
Phosphorus fractionation in volcanic lake sediments (Azores - Portugal). Chemosphere (2007) 0.91
Purinergic modulation of the evoked release of [3H]acetylcholine from the hippocampus and cerebral cortex of the rat: role of the ectonucleotidases. Eur J Neurosci (1994) 0.90
The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease. Neuroreport (1999) 0.90
Morphology of reproductive accessory glands in eight species of blood-feeding Hemiptera (Hemiptera, Reduviidae) insect vectors of Chagas disease. Acta Trop (2012) 0.90
Renal microangiopathy of the hemolytic-uremic syndrome in childhood. Nephron (1976) 0.90
Interleukin-6 upregulates neuronal adenosine A1 receptors: implications for neuromodulation and neuroprotection. Neuropsychopharmacology (2007) 0.90
Endogenous adenosine modulates long-term potentiation in the hippocampus. Neuroscience (1994) 0.90
Essential fatty acid deficiency in human adults during total parenteral nutrition. Ann Intern Med (1975) 0.89
Tuning and fine-tuning of synapses with adenosine. Curr Neuropharmacol (2009) 0.89
Leptospirosis in cattle: a challenging scenario for the understanding of the epidemiology. Transbound Emerg Dis (2014) 0.89
Molecular diagnostics of leptospirosis in horses is becoming increasingly important. Vet Microbiol (2011) 0.89
Pharmacological characterization of the receptor involved in chemoexcitation induced by adenosine. Br J Pharmacol (1986) 0.89
ATP; related nucleotides and adenosine on neurotransmission. Life Sci (1978) 0.89
Facilitation by arachidonic acid of acetylcholine release from the rat hippocampus. Brain Res (1999) 0.88
Catabolism of plasma enzymes, as studied with 125I-labeled lactate dehydrogenase-1 in the rabbit. Clin Chem (1976) 0.88
Adenosine and neuronal plasticity. Life Sci (1997) 0.88
Acute effects of peritoneal dialysis solutions on appetite in non-uremic rats. Kidney Int (2001) 0.88
Age-dependent decrease in adenosine A1 receptor binding sites in the rat brain. Effect of cis unsaturated free fatty acids. Eur J Biochem (2001) 0.88
Adenosine by activating A1 receptors prevents GABAA-mediated actions during hypoxia in the rat hippocampus. Brain Res (1996) 0.87
Adherence to drug therapy in kidney disease. Braz J Med Biol Res (2011) 0.87
Urinary PCR as an increasingly useful tool for an accurate diagnosis of leptospirosis in livestock. Vet Res Commun (2013) 0.87
The vertical dispersion of Anopheles (Kerteszia) cruzi in a forest in southern Brazil suggests that human cases of malaria of simian origin might be expected. Mem Inst Oswaldo Cruz (1985) 0.87
Roxithromycin reduces cyclosporine-induced gingival hyperplasia in renal transplant patients. Transplant Proc (2008) 0.87
Cold: a risk factor for stroke? J Neurol (1995) 0.86
ESRD modality selection into the 21st century: the importance of non medical factors. ASAIO J (1997) 0.86
Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease? Eur J Clin Nutr (2006) 0.86
Inhibition of [3H] gamma-aminobutyric acid release by kainate receptor activation in rat hippocampal synaptosomes. Eur J Pharmacol (1997) 0.86
Ecto-AMP deaminase blunts the ATP-derived adenosine A2A receptor facilitation of acetylcholine release at rat motor nerve endings. J Physiol (2003) 0.86